Newsroom

Stay up to date with what’s happening at ONO PHARMA USA.

Doctor meeting with a patient
ONO PHARMA USA Announces 2025 Golden Ticket Competition Now Accepting Applications from Innovative Startups
Press Release
April 25, 2025
Ono Pharma Announces an Oral Presentation on Phase 2 Data for Tirabrutinib and a Poster Session on ONO-4578 (EP4 Antagonist) at the American Society of Clinical Oncology (ASCO) Annual Meeting
Press Release
April 24, 2025
Ono Pharmaceutical Co., Ltd. Announced 2024 Q3 Financial Results
Press Release
February 3, 2025
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
Press Release
December 6, 2024
ONO Pharmaceutical Co., Ltd. Announced 2024 Q2 Financial Results
Press Release
October 31, 2024
ONO PHARMA USA Announces Support for Conquer Cancer®, the ASCO Foundation
Press Release
June 24, 2024
ONO PHARMA USA Announces 2024 Golden Ticket Competition Now Accepting Applications from Innovative Startups
Press Release
May 2, 2024
ONO PHARMA Announces Enrollment Is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL
Press Release
March 21, 2024
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Press Release
March 11, 2024
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
Press Release
February 13, 2024